Haemonetics Corporation (HAE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Haemonetics Corporation (HAE) has a cash flow conversion efficiency ratio of 0.089x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($70.94 Million) by net assets ($796.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Haemonetics Corporation market cap and net worth for the company's overall valuation and market capitalisation.
Haemonetics Corporation - Cash Flow Conversion Efficiency Trend (1992–2026)
This chart illustrates how Haemonetics Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Haemonetics Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Haemonetics Corporation ranked by their cash flow conversion efficiency. Explore Haemonetics Corporation earnings quality ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
LandBridge Company LLC
NYSE:LB
|
0.051x |
|
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
-0.032x |
|
KANSAI PAINT SPON.ADR/1/2
F:KAP0
|
N/A |
|
China Resources Double-Crane Pharmaceutical Co Ltd
SHG:600062
|
0.040x |
|
Legend Holdings Corporation
F:1PC
|
-0.009x |
|
Inari Amertron Bhd
KLSE:0166
|
0.027x |
|
Harmony Biosciences Holdings
NASDAQ:HRMY
|
0.093x |
|
Qingdao Rural Commercial Bank Corp Class A
SHE:002958
|
0.250x |
Annual Cash Flow Conversion Efficiency for Haemonetics Corporation (1992–2026)
The table below shows the annual cash flow conversion efficiency of Haemonetics Corporation from 1992 to 2026. View Haemonetics Corporation (HAE) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | $893.76 Million | $293.22 Million | 0.328x | +48.19% |
| 2025-03-31 | $820.84 Million | $181.72 Million | 0.221x | +16.93% |
| 2024-03-31 | $959.96 Million | $181.75 Million | 0.189x | -43.28% |
| 2023-03-31 | $818.00 Million | $273.06 Million | 0.334x | +45.22% |
| 2022-03-31 | $749.42 Million | $172.26 Million | 0.230x | +54.57% |
| 2021-03-31 | $731.67 Million | $108.81 Million | 0.149x | -44.82% |
| 2020-03-31 | $587.11 Million | $158.22 Million | 0.269x | +13.00% |
| 2019-03-31 | $667.87 Million | $159.28 Million | 0.238x | -18.56% |
| 2018-03-31 | $752.43 Million | $220.35 Million | 0.293x | +35.59% |
| 2017-03-31 | $739.61 Million | $159.74 Million | 0.216x | +27.60% |
| 2016-03-31 | $719.98 Million | $121.86 Million | 0.169x | +9.95% |
| 2015-03-31 | $826.12 Million | $127.18 Million | 0.154x | -7.36% |
| 2014-03-31 | $839.61 Million | $139.52 Million | 0.166x | +50.25% |
| 2013-03-31 | $769.18 Million | $85.07 Million | 0.111x | -29.50% |
| 2012-03-31 | $735.08 Million | $115.32 Million | 0.157x | -12.81% |
| 2011-03-31 | $686.14 Million | $123.45 Million | 0.180x | -18.33% |
| 2010-03-31 | $593.12 Million | $130.67 Million | 0.220x | +2.21% |
| 2009-03-31 | $539.88 Million | $116.36 Million | 0.216x | +37.14% |
| 2008-03-31 | $494.19 Million | $77.67 Million | 0.157x | -9.79% |
| 2007-03-31 | $479.65 Million | $83.56 Million | 0.174x | -10.13% |
| 2006-03-31 | $441.65 Million | $85.62 Million | 0.194x | -3.32% |
| 2005-03-31 | $355.13 Million | $71.21 Million | 0.201x | -24.82% |
| 2004-03-31 | $279.75 Million | $74.61 Million | 0.267x | +36.35% |
| 2003-03-31 | $223.24 Million | $43.67 Million | 0.196x | +43.70% |
| 2002-03-31 | $236.82 Million | $32.24 Million | 0.136x | -51.91% |
| 2001-03-31 | $215.52 Million | $61.01 Million | 0.283x | +9.31% |
| 2000-03-31 | $206.44 Million | $53.47 Million | 0.259x | +70.53% |
| 1999-03-31 | $221.90 Million | $33.70 Million | 0.152x | +44.95% |
| 1998-03-31 | $194.70 Million | $20.40 Million | 0.105x | -11.59% |
| 1997-03-31 | $225.30 Million | $26.70 Million | 0.119x | -53.07% |
| 1996-03-31 | $217.00 Million | $54.80 Million | 0.253x | +212.75% |
| 1995-03-31 | $193.20 Million | $15.60 Million | 0.081x | -51.91% |
| 1994-03-31 | $160.80 Million | $27.00 Million | 0.168x | -40.74% |
| 1993-03-31 | $126.70 Million | $35.90 Million | 0.283x | +36.55% |
| 1992-03-31 | $90.60 Million | $18.80 Million | 0.208x | -- |
About Haemonetics Corporation
Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and solutions, as well as integrated information tech… Read more